Overview

A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Status:
Active, not recruiting

Trial end date:
2022-04-23

Target enrollment:

Participant gender:

Summary

The purpose of this Phase 1 clinical trial is to help us understand how the drug is changed and eliminated from your body after you take it, the safety, and the the extent to which dise effects can be tolerated of PF-07321332 when PF-07321332 and ritonavir are given to healthy adult Chinese participants.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Ritonavir